Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dentin proteolytic enzymes are a group of host-derived enzymes, primarily matrix metalloproteinases (MMPs) and cysteine cathepsins, that are sequestered within the mineralized dentin matrix during tooth formation (Tjäderhane et al., 2015, https://doi.org/10.1177/0022034515582224). The most prominent members of this group include matrix metalloproteinases such as MMP-2, MMP-8, and MMP-9, as well as various cysteine cathepsins like cathepsin B and K (Tersariol et al., 2010, https://doi.org/10.1177/0022034510363380). These enzymes remain inactive until they are exposed and activated by acidic challenges, such as those from cariogenic bacteria or the acid-etching step in dental bonding procedures (Mazzoni et al., 2015, https://doi.org/10.1016/j.jdent.2014.08.015). Once active, they catalyze the degradation of type I collagen, which constitutes the bulk of the dentin organic matrix. This degradation is a major factor in the progression of dental caries and the long-term failure of resin-dentin bonds, as the enzymes break down the hybrid layer formed during restoration (Carrilho et al., 2007, https://doi.org/10.1177/154405910708600115). Therapeutic interventions often involve the use of protease inhibitors like chlorhexidine or cross-linking agents to preserve the structural integrity of the dentin and improve the longevity of dental restorations (Scaffa et al., 2012, https://doi.org/10.1177/0022034512445202).
Inhibition of proteolytic activity through competitive binding, chelation of essential metal ions such as zinc and calcium, or collagen cross-linking to prevent enzymatic access to cleavage sites.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin proteolytic enzymes.